Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
The discovery that some fluorescent proteins are sensitive to magnets could lead to the development of switchable drugs and biosensors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback